Lucid Diagnostics Inc.
NASDAQ:LUCDMedical - Devices
+$0.04 today
- Market cap
- $79.38M
- Beta
- 1.08
- P/E (TTM)
- -2.3
- EPS (TTM)
- -$0.44
Volume 2.70M
Average 0.84M
LUCD Pre-Tax Margin
Income before tax as a percentage of revenue.
Lucid Diagnostics Inc.NASDAQ: LUCD
Pre-Tax Margin · Q1 FY2026 · quarter ended Mar 2026
Pre-tax margin widens to -1107.4%
Pre-tax margin was -1107.4% in Q1 FY2026, up 2142.4 pp from a year earlier. On a trailing-twelve-month basis it was -876.7%, up 604.8 pp year over year. Over 3 fiscal years it widened by 13666.8 pp.
Context
- Pre-tax margin widened in 2 of the last 3 fiscal years.
Sources:Income StatementText generated from reported figures; not investment advice.
Pre-Tax Margin history
Percent of revenue · from the income statement
- Latest · FY2025
- -1232.7%
- Year-over-year change
- -185.1pp
| Period | Period end | Pre-Tax Margin | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | -1232.7% | -185.1pp |
| FY2024 | 2024-12-31 | -1047.6% | +1121.5pp |
| FY2023 | 2023-12-31 | -2169.1% | +12730.4pp |
| FY2022 | 2022-12-31 | -14899.5% | -9283.9pp |
| FY2021 | 2021-12-31 | -5615.6% | — |
Pre-Tax Margin vs competitors
How LUCD compares with its peers on the latest reported figures
- LUCD's LTM Mar 2026 pre-tax margin of -876.7% is the 6th highest of the 10 companies compared; the peer median is -468.0%.
- Its year-over-year change of +604.8 pp is the highest of 9, against a peer median of -11.6 pp.
- Over three fiscal years its change of +13666.8 pp compares with a peer median of +20.2 pp.
| Company | Period | LTM level | YoY | 3-year change |
|---|---|---|---|---|
| LTM Mar 2026 | -15.6% | +26.5 pp | +31.0 pp | |
| LTM Mar 2026 | -43.0% | -28.6 pp | +77.1 pp | |
| LTM Mar 2026 | -62.7% | +16.9 pp | +9.5 pp | |
| LTM Mar 2026 | -145.7% | +5.4 pp | +218.1 pp | |
| LTM Mar 2026 | -468.0% | +96.8 pp | +177.7 pp | |
| LTM Mar 2026 | -876.7% | +604.8 pp | +13666.8 pp | |
IRDOpus Genetics, Inc. | LTM Mar 2026 | -892.4% | -462.9 pp | -395.0 pp |
| LTM Mar 2026 | -1162.4% | -1015.4 pp | -1174.9 pp | |
AVRAnteris Technologies Global Corp. | LTM Mar 2026 | -5116.2% | -1836.7 pp | -3970.6 pp |
| LTM Mar 2026 | -90325.9% | — | — | |
| Peer median (excluding LUCD) | -468.0% | -11.6 pp | +20.2 pp | |
Competitors are the stored peer set for LUCD. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 500K | 377K | 2.43M | 4.35M | 4.71M |
| Cost of Revenue | 585K | 3.61M | 8.48M | 8.27M | 7.54M |
| Gross Profit | (85K) | (3.24M) | (6.05M) | (3.92M) | (2.84M) |
| Gross Margin | -17.0% | -858.6% | -249.2% | -90.2% | -60.3% |
| Research & Development | 9.3M | 11.47M | 7.25M | 5.99M | 5.68B |
| Selling, General & Admin | 18.04M | 39.82M | 35.66M | 36.62B | 41.58B |
| Operating Expenses | 27.33M | 52.93M | 42.43M | 42.13M | 46.8M |
| Depreciation & Amortization | 4K | 1.94M | 2.5M | 1.17M | 872K |
| EBITDA | (27.42M) | (54.23M) | (49.75M) | (44.34M) | (57.12M) |
| EBITDA Margin | -5483.0% | -14383.8% | -2049.1% | -1020.2% | -1213.7% |
| Operating Income | (27.42M) | (56.17M) | (48.48M) | (46.05M) | (49.64M) |
| Operating Margin | -5483.8% | -14899.5% | -1996.8% | -1059.6% | -1054.8% |
| Interest Income | 0 | 88K | 424K | 322K | 386K |
| Interest Expense | 659K | 8K | 416K | 26K | 22K |
| Other Income / Expenses | (659K) | 0 | (4.18M) | 523K | (8.37M) |
| Income Before Tax | (28.08M) | (56.17M) | (52.67M) | (45.53M) | (58.01M) |
| Pre-Tax Margin | -5615.6% | -14899.5% | -2169.1% | -1047.6% | -1232.7% |
| Income Tax Expense | 0 | 0 | 0 | 0 | 0 |
| Net Income | (28.08M) | (56.17M) | (52.67M) | (45.53M) | (58.01M) |
| Net Margin | -5615.6% | -14899.5% | -2169.1% | -1047.6% | -1232.7% |
| EPS (Basic) | (0.78) | (1.55) | (1.26) | (1.05) | (0.69) |
| EPS (Diluted) | (0.78) | (1.55) | (1.26) | (1.05) | (0.69) |
| Weighted Avg Shares | 36.06M | 36.17M | 41.76M | 50.52M | 101.95M |
| Weighted Avg Shares (Diluted) | 36.06M | 36.17M | 41.76M | 50.52M | 101.95M |
Lucid Diagnostics Inc.
NASDAQ:LUCD
Intrinsic Alpha fair value
Locked
Current Price
$0.41
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.